Results 231 to 240 of about 129,342 (334)

Production of Granulocyte-Macrophage Colony-Stimulating Factors (GM-CSF) by Various Mammalian Cell Lines Cultured in a Protein-Free Synthetic Medium

, 1980
Kazuko Tsuneoka, Mikio Shikita
openalex   +2 more sources

TP53‐Mutated Acute Myeloid Leukemia: Unanswered Questions

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT TP53‐mutated acute myeloid leukemia (AML) remains one of the most treatment‐resistant hematologic malignancies, with poor overall survival despite advancements in therapeutic strategies. The loss of functional p53 compromises DNA repair, apoptosis, and genomic stability, rendering both conventional and novel therapies largely ineffective. This
Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Caterina Labanca, Giulio Caridà, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Noemi Puccio, Antonino Neri, Fortunato Morabito, Massimo Gentile   +11 more
wiley   +1 more source

Addition of granulocyte macrophage colony stimulating factor (GM-CSF) during in vitro oocyte maturation improves embryo development in a mouse model of advanced maternal age. [PDF]

J Reprod Dev
Saini A, McPherson NO, Nottle MB.
europepmc   +1 more source

Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. [PDF]

PLoS One, 2022
Karmacharya MB, Hada B, Park SR, Kim KH, Choi BH.   +4 more
europepmc   +1 more source

A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection

IJU Case Reports, Volume 8, Issue 4, Page 423-426, July 2025.
ABSTRACT Introduction Hemophagocytic lymphohistiocytosis (HLH) is characterized by macrophage and cytotoxic lymphocyte hyperactivation, fever, pancytopenia, liver dysfunction, and abnormal coagulation. However, no specific treatments have been established for HLH caused by immune checkpoint inhibitors.
Tomoko Honda, Hirohito Naito, Yu Osaki, Yoichiro Tohi, Yuki Matsuoka, Takuma Kato, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto   +9 more
wiley   +1 more source

Elevated Salt or Angiotensin II Levels Induce CD38+ Innate Immune Cells in the Presence of Granulocyte-Macrophage Colony Stimulating Factor. [PDF]

Cells
Smith HL, Goodlett BL, Navaneethabalakrishnan S, Mitchell BM.   +3 more
europepmc   +1 more source

[Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up]. [PDF]

Dermatologie (Heidelb), 2023
Jaschke E, Umlauft J, Palmer-Reichel K, Oberaigner W, Schmuth M.   +4 more
europepmc   +1 more source

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer [PDF]

, 1994
Andrea Ardizzoni, M. Venturini, M.R. Sertoli, PG Giannessi, Fulvio Brema, Marco Danova, Franco Testore, G Mariani, MC Pennucci, Paola Queirolo, S Silvestro, Paolo Bruzzi, Rita Lionetto, Fabio Latini, R. Rosso   +14 more
openalex   +1 more source

The Interplay of Cross‐Organ Immune Regulation in Inflammation and Cancer

MedComm, Volume 6, Issue 7, July 2025.
Organs interact dynamically through immune regulation, influencing systemic immune responses and disease progression. We review molecular and cellular mechanisms of cross‐organ immune regulation in inflammation and cancer, focusing on gut, liver, and brain interactions with other organs.
Jie Dou, Jinzuo Jiang, Yangtao Xue, Xiaoqi Jiang, Yongzhuo Jiang, Peng Xiao, Junjie Xu   +6 more
wiley   +1 more source

Granulocyte-Macrophage Colony-Stimulating Factor in Combination With Chemoradiation for Recurrent or Metastatic Cervical Cancer. [PDF]

Cureus
Zhang N, Guo MF.
europepmc   +1 more source